Hepion Pharmaceuticals, Inc. Annual Return On Equity in % from 2014 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Hepion Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2024.
  • Hepion Pharmaceuticals, Inc. Return On Equity for the quarter ending December 31, 2024 was -599 %, a 166% decline year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Return On Equity for 2024 was -599 %, a 166% decline from 2023.
  • Hepion Pharmaceuticals, Inc. annual Return On Equity for 2023 was -225 %, a 251% decline from 2022.
  • Hepion Pharmaceuticals, Inc. annual Return On Equity for 2022 was -64.2 %, a 108% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -599 -374 -166% Jan 1, 2024 Dec 31, 2024
2023 -225 -161 -251% Jan 1, 2023 Dec 31, 2023
2022 -64.2 -33.3 -108% Jan 1, 2022 Dec 31, 2022
2021 -30.9 +60.3 +66.1% Jan 1, 2021 Dec 31, 2021
2020 -91.2 -34.6 -61.2% Jan 1, 2020 Dec 31, 2020
2019 -56.6 +379 +87% Jan 1, 2019 Dec 31, 2019
2018 -436 +80 +15.5% Jan 1, 2018 Dec 31, 2018
2017 -516 +575 +52.7% Jul 1, 2016 Jun 30, 2017
2016 -1.09K -810 -289% Jul 1, 2015 Jun 30, 2016
2015 -280 -471 -247% Jul 1, 2014 Jun 30, 2015
2014 191 Jul 1, 2013 Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.